“…Over the last decade, interest regarding the use of ML algorithms across diverse disciplines in pharmaceutical design and development has grown [ 11 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ]. While ML models have been produced to optimise lipid-based formulation (LBF) development [ 3 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ], the application of more novel ML approaches for bio-enabling formulations currently focuses on solid dispersions (SDs) [ 21 , 34 , 35 ]. However, their application to LBFs, particularly supersaturated LBFs (sLBFs), remains unexplored.…”